Search

Your search keyword '"Fortes F"' showing total 203 results

Search Constraints

Start Over You searched for: Author "Fortes F" Remove constraint Author: "Fortes F"
203 results on '"Fortes F"'

Search Results

101. Discriminating organic carbon from endokarstic moonmilk-type deposits by LIBS. The case of a natural carbonated Martian analogue.

102. Therapeutic response to four artemisinin-based combination therapies in Angola, 2021.

103. CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles.

104. Assessment of the yellow fever outbreak in Angola from December 2015 through December 2016: A retrospective study.

105. Impact of an intervention program on drug adherence in patients with ulcerative colitis: Randomized clinical trial.

106. The metabolic response of Araucaria angustifolia embryogenic cells to heat stress is associated with their maturation potential.

107. Multi-analytical characterization of an oncoid from a high altitude hypersaline lake using techniques employed in the Mars2020 and Rosalind Franklin missions on Mars.

108. Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019.

109. Risk assessment of N- nitrosamines in food.

110. Wasting, Stunting, and Anemia in Angolan Children after Deworming with Albendazole or a Test-and-Treat Approach for Intestinal Parasites: Binary Longitudinal Models with Temporal Structure in a Four-Arm Randomized Trial.

111. Size-dependent synergetic seeding effects in the inspection of airborne dry nanoaerosols by LIBS.

112. Reply to Rasmussen and Ringwald, "Continued Low Efficacy of Artemether-Lumefantrine in Angola?"

113. Impact of Annual Albendazole versus Four-Monthly Test-and-Treat Approach of Intestinal Parasites on Children Growth-A Longitudinal Four-Arm Randomized Parallel Trial during Two Years of a Community Follow-Up in Bengo, Angola.

114. Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019.

115. Inflammaging in Endemic Areas for Infectious Diseases.

116. Attrition, physical integrity and insecticidal activity of long-lasting insecticidal nets in sub-Saharan Africa and modelling of their impact on vectorial capacity.

117. Malaria Test, Treat and Track policy implementation in Angola: a retrospective study to assess the progress achieved after 4 years of programme implementation.

118. Insect-specific flaviviruses and densoviruses, suggested to have been transmitted vertically, found in mosquitoes collected in Angola: Genome detection and phylogenetic characterization of viral sequences.

119. The V410L knockdown resistance mutation occurs in island and continental populations of Aedes aegypti in West and Central Africa.

120. Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection.

121. Malaria Parasite Density in Individuals with Different Rapid Diagnostic Test Results and Concentrations of HRP2 Antigen.

122. Performance of Antigen Concentration Thresholds for Attributing Fever to Malaria among Outpatients in Angola.

123. Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay.

124. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.

125. Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.

126. Posttreatment HRP2 Clearance in Patients with Uncomplicated Plasmodium falciparum Malaria.

127. Estimating the Added Utility of Highly Sensitive Histidine-Rich Protein 2 Detection in Outpatient Clinics in Sub-Saharan Africa.

128. Malaria overdiagnosis and subsequent overconsumption of antimalarial drugs in Angola: Consequences and effects on human health.

129. Evaluating malaria case management at public health facilities in two provinces in Angola.

130. Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests.

131. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.

132. Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.

133. Molecular epidemiology of rotavirus in four provinces of Angola before vaccine introduction.

134. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.

135. Effects of autonomic balance and fluid and electrolyte changes on cardiac function in infarcted rats: A serial study of sexual dimorphism.

136. Infection by Intestinal Parasites, Stunting and Anemia in School-Aged Children from Southern Angola.

137. Reply to "no robust evidence of lumefantrine resistance".

138. Spatio-temporal variations of Anopheles coluzzii and An. gambiae and their Plasmodium infectivity rates in Lobito, Angola.

139. The Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.

140. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.

141. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.

142. Impact of a training course on the quality of malaria diagnosis by microscopy in Angola.

143. Asymptomatic infection in individuals from the municipality of Barcelos (Brazilian Amazon) is not associated with the anti-Plasmodium falciparum glycosylphosphatidylinositol antibody response.

144. Human antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola.

145. Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola.

146. Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil.

147. Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.

148. Spectrochemical study for the in situ detection of oil spill residues using laser-induced breakdown spectroscopy.

149. Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.

150. Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.

Catalog

Books, media, physical & digital resources